GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Expensive Performer
2870.7000 -8.10 (-0.28%)
NSE May 15, 2025 10:26 AM
Volume: 54,207
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
05 Aug 2024
2870.70
-0.28%
buy
by ICICI Securities Limited
Target: 2640 | Target met
ICICI Securities Limited
GlaxoSmithKline Pharmaceuticals’ (GSK) Q1FY25 result was ahead of our expectations driven by mixed improvement and curb in overhead cost.
 
GlaxoSmithKline Phar.. has an average target of 2630.00 from 2 brokers.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Market opens flat, Eicher Motors' Q4 net profit grows 27.3% YoY to Rs 1,362.2 crore
Trendlyne Marketwatch | 15 May 2025, 10:02AM
A car running on flat tires: Pakistan's economy is struggling
The Baseline | 15 May 2025, 09:48AM
Chart of the week: From partnerships to diversification: Dixon Technologies powers ahead to new highs
The Baseline | 14 May 2025, 09:48AM